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Acoustic rhinometry, rhinomanometry and Inspiratory Peak Nasal Flow (IPNF) are used in order 
to objectively assess nasal patency. These are expensive not very practical tests, except for IPNF, 
which is a fast, simple and low cost method. 
Objective: To assess IPNF in healthy individuals complaining of nose obstruction caused by allergic 
rhinitis. 
Method: IPNF use in 78 individuals with and without rhinitis symptoms. 
Study design: Contemporary cross-sectional cohort. 
Results: IPNF showed significant results for nasal obstruction, rhinorrhea, pruritus, sneezes and 
tearing (p < 0.001). There was no correlation between the presence of nasal septum deviation and 
IPNF (p = 0.561). We found a positive correlation between IPNF and the Visual Analogue Scale 
(VAS) for nasal obstruction (p = 0.002). In the multiple linear regression model, there was a statistical 
significance between the values found in IPNF with allergic rhinitis and age (p = 0.005 and p = 0.023 
respectively). 
Conclusion: IPNF proved to be a reliable method to detect changes in nasal patency, by obstructive 
causes as well as inflammatory causes, with an acceptable level of statistical significance, simple, 
easy to handle, inexpensive and reproducible.
ORIGINAL ARTICLE
Braz J Otorhinolaryngol.
2011;77(4):473-80. BJORL
Keywords: 
nasal obstruction,
rapid evaluation, 
rhinitis.
.org
77(4)-Inglês.indb   473 28/07/2011   13:44:49
474
Brazilian Journal of otorhinolaryngology 77 (4) July/august 2011
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
INTRODUCTION
Nasal breathing is predominant in the human race, 
from birth all the way to adulthood. Mouth breathing or 
oral-nasal breathing is physiologically used in cases of 
higher demand, such as in the practice of physical exer-
cises. More than half of the resistance against airflow in 
the respiratory tract can be found in the nose. The nasal 
valve is the region between the nasal septum, the anterior 
portion of the inferior turbinate and the lower border of 
the inferior lateral cartilage. It is the main mechanism 
regulating nasal airflow1,2.
Besides respiratory well-being, other functions such 
as swallowing, sleep quality, olfaction, paranasal sinus 
aeration and middle ear health, among others, depend 
on proper nasal functioning. Therefore, the development 
of objective assessment techniques of the nasal function 
is fundamental to diagnose deviations from normal and 
proper patient follow up.
Ideally, objective tests which assess nasal patency 
must be confortable, accurate, standardized and easy to 
perform, clinically applicable and must not impact nasal 
anatomo-physiology. Moreover, its reproducibility is fun-
damental, which is the test’s capacity to produce consistent 
results when independently repeated3. The most com-
monly used objective methods to study nasal airflow are 
computerized rhinomanometry, acoustic rhinometry and 
Nasal Inspiratory Peak Flow (NIPF)4. The first assesses the 
air flow in its entire extension in the nasal cavity, the sec-
ond measures the cross-sectional areas in predetermined 
points in the nasal cavity5 and NIPF, as the very name says, 
measures the nasal inspiratory peak flow6.
NIPF is inexpensive, easily applied, fast, portable, 
simple to measure, does not depend on computers to 
analyze the data and has good reproducibility. Both rhi-
nometry as well as the NIPF are accurate to detect nasal 
obstructive changes, with 0.77 vs. 0.66 of sensitivity, re-
spectively. The methods’ specificity is 0.8 with a diagnostic 
accuracy around 0.757. The cutting value for the peak flow 
measured by the NIPF, according to some authors, is less 
than 120 l/min, with a difference of approximately 35% 
before and after the use of a nasal vasoconstriction agent8. 
Notwithstanding, these findings are associated with the 
results from foreign studies, and there are no Brazilian 
studies which corroborate for a standardization of values 
found in the NIPF associated with the Brazilian Population. 
The latter, with 180 million inhabitants, is highly mixed, 
with the following ethnic composition: whites (49.4%), 
browns (42.3%), blacks (7.4%), yellow (0.5%) and Indians 
(0.3%)10, each one with its own particular nasal anatomi-
cal characteristics, with statistical differences in relation 
to feeding habits, socioeconomical characteristics, climate 
and dressing habits.
The present paper aims at assessing NIPF as a 
method to measure nasal airflow changes and compare the 
values found upon NIPF in individuals with nasal obstruc-
tion by allergic rhinitis and normal controls.
MATERIALS AND METHODS
The present paper represents a contemporary, 
cross-sectional cohort study, in which the variable studied 
is the NIPF behavior in a population of healthy individuals 
and individuals with rhinitis. The individuals voluntarily 
participated in the study, and they were selected in a 
non-randomized fashion. This study was approved by the 
Ethics and Research Committee under protocol number 
824/2009. The study started after the participants signed 
two copies of the informed consent form, which were also 
signed by the examining physician.
The sample counted on 78 volunteers with ages 
between 19 and 67 years, encompassing patients, patient 
companions, physicians, hospital and clinic employees and 
other administrative professionals from the institution. All 
the volunteers were examined by the same ENT physi-
cian by means of an interview, physical exam (anterior 
rhinoscopy and nasal fiber optic exam), and the patients 
answered the standardized signs and symptoms question-
naire. At this point, rhinitis was diagnosed according to the 
data collected (interview, physical exam and nasal fibros-
copy)9-11; and then, the participants were broken down into 
two groups: those with rhinitis and those without it. After 
that, NIPF was employed in three consecutive individual 
takes in order to obtain the highest measure. Exclusion 
criteria were: individuals with upper airway infections on 
the day of the exam or in the 14 days prior to it; participants 
who chronically used nasal decongestants, anti-histamine, 
anticholinergic or steroid (topic nasal or systemic) agent; 
nasal cavity malformation; nasal polyps or nasal masses, 
or those who drank alcohol or smoked during the exam. 
Upon physical exam, the following items were valued: 
nasal conchae hypertrophy, rhinorrhea, nasal septum 
deviations, mucosal aspects (nasal conchae hypertrophy, 
rhinorrhea, nasal septum deviations, mucosal aspects 
(color, impregnations, signs of bleeding and crust), other 
changes of the nasal frame and pyramid and the nasal 
meatuses. Smokers were included, as well as those with 
nasal septum deviation. All participants were required to 
report on the use of any kind of drug prior to the assess-
ment. The examinations were carried out in the outpatient 
wards of the institutions, where there already are facilities 
for it - proper room, proper chair, table, air conditioning, 
maintaining room temperature between 22°C-24°C. The 
material used to disinfect the nasal fibroscope and NIPF 
were chlorhexidine, 70% alcohol, hydrogen peroxide and 
soap. We used an Olympus ENF type P4 fibroscope and 
a Clement Clark International Limited model IN-CHECK 
ORAL ATM device to analyze NIPF. This device is made 
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up of a 20cm plastic cylinder, with a diameter varying 
between 3 and 4 cm, with two ends: one of them has 
holes from where the inspired air passes, the other end 
is coupled to a facial mask which is in contact with the 
volunteer’s face. Inside the cylinder there is a diaphragm 
which moves according to the maximum air inflow. The 
diaphragm stops moving when flow stops, then measure-
ment is carried out in a scale which varied between 30-370 
liters/minute, which is branded on the cylinder’s surface 
(Figures 1 and 2).
The devices were disinfected immediately after 
use. The measures were carried out with the following 
specifications: 1) Acclimatization - participant seating for 20 
NIPF was measured three consecutive times with a 1 
minute interval between them4,6. The exam technique was 
based on measuring the participant’s nasal inspiratory flow 
when standing up, with the device coupled to the nose’s 
anterior region through a small mask connected to a plastic 
cylinder through which the forced inspired air passes. The 
result is seen immediately, similarly to the well-known 
expiratory peak flow routinely used in pneumology to 
study the pulmonary expiratory capacity.
Figure 1. Nasal Inspiratory Peak Flow (NIPF).
Figure 2. NIPF application.
minutes in the test area. During this period, the question-
naire was filled out and the physical exam was made; 2) 
The participant filled out the visual-analogue scale (VAS) 
concerning nasal obstruction (Figure 3); 3) The patient’s 
Figure 3. Visual-analogue scale used for nasal obstruction
The data was descriptively analyzed per absolute 
(n) and relative(%) frequencies of the categorical variables. 
For continuous variables we used the mean, standard 
deviation, median, first and third quartile, maximum and 
minimum values.
The Student’s t  and variance analysis (ANOVA) 
tests were employed in order to compare the NIPF ac-
cording to demographic and clinical characteristics. The 
Spearman linear correlation coefficient was used in order 
to analyze the correlation between NIPF and VAS and age 
of the subjects in the sample. A multiple linear regression 
model was adjusted in order to analyze the impact of some 
clinical and demographic characteristics on the NIPF. We 
included in the model those variables which had a p <0.25 
upon multivariate analysis.
The SAS 9.1.3 software (SAS Institute Inc., Cary, 
NC, USA, 2002-2003) was utilized for data analysis pur-
poses and a statistical significance level of 5% was used.
RESULTS
Table 1a depicts the clinical and demographic 
characteristics of this sample with 78 individuals, mostly 
females - n = 47 (60.3%) in relation to males n=31 (39.7%). 
We also noticed that 80.8% of the individuals were whites, 
95% had not had upper airway infections in the past 14 
days, and only 2.7% had had prior nasal or palate surgery. 
In our sample, 65 individuals (83.3%) did not smoke or 
had stopped for more than 5 years.
As far as rhinitis symptoms go, 36 participants had 
nasal obstruction (46.2%). No rhinorrhea, pruritus and 
sneezing were seen in 79.5%, 65.4% and 83.3%, respec-
tively. This represents a sample of individuals without a 
predominance of these cardinal symptoms for diagnosing 
rhinitis; thus, most are normal (55.1%). We have noticed 
that 74% of the individuals did not have nasal septum devi-
ation and 14.1% had nasal secretion upon nasal-fibroscopy.
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Table 1a. Sample clinical and demographic characteristics.
Characteristics n %
Gender   
M 31 39.7
F 47 60.3
Ethnics   
White 63 80.8
Black 6 7.7
Other 9 11.5
Smoking   
No 65 83.3
Yes 13 16.7
Nasal obstruction   
No 36 46.2
Yes 42 53.8
Nasal septum deviation   
No 58 74.4
Yes 20 25.6
Inferior turbinate hypertrophy   
0 10 12.8
1 14 17.9
2 31 39.7
3 23 29.5
Nasal secretion   
No 67 85.9
Yes 11 14.1
Rhinitis   
No 43 55.1
Yes 35 44.9
(n=78)
Table 1b depicts a mean age of 36.8 years, with 
ages varying between 19 and 67 years. As to the Visual 
Analogue Scale for nasal obstruction, the mean value found 
was 3.7, which score varies between 0 and 10.
Table 2 depicts the chronic use of nasal decon-
gestants and anti-histamine agents was only prevalent in 
rhinitis patients, in 14.3%, which was not found in those 
without rhinitis, with a p-value of p=0.008. Of the par-
ticipants who reported having been exposed to inhaling 
chemical products, 25.7% had rhinitis and 11.6% did not, 
with a p-value of p=0.049. Nasal obstruction was found in 
85.7% of the patients with rhinitis and in 27.9% of those 
without it (p<0.001). Nasal pruritus was also prevalent 
among rhinitis patients, with 65.7%, compared to the 9.3% 
found among those without it (p<0.001). Rhinorrhea was 
seen in 42.9% of those with rhinitis and in 2.3% of those 
without it (p<0.001). Sneezing and tearing were also more 
Table 1b. Sample demographic and clinical characteristics.
 AGE
Visual-analogue scale for 
nasal obstruction
n 78 78
Mean 36,8 3,7
Standard deviation 12,2 2,9
Median 33 3,5
1st quartile 27 1
3rd quartile 48 6
Minimum 19 0
Maximum 67 10
(n=78)
prevalent among rhinitis patients, with 68.6% and 34.3% 
compared to 7% and 2,3% of those who do not have it, 
respectively, both with a p-value of p<0.001. Nasal secre-
tion noticed by nasal fibroscopy was seen in 28.6% of the 
rhinitis patients and in 2.3% of those without it (p<0.001). 
The variables: nasal septum, mold, moisture, smoking, a 
pet in the house, were not statistically significant in the 
linear regression model.
On Table 3, the mean NIPF values for healthy pa-
tients who reported no obstruction was 151.4 l/min and 
123.6 l/min for those who reported having nasal obstruc-
tion (p=0.002). As far as nasal conchae hypertrophy (CH) 
is concerned, by means of the nasal endoscopic exam, the 
mean NIPF value found for grade 0 CH (no hypertrophy) 
was 163.0 l/min; for grade I CH, the mean value was 141.2 
l/min; for grade II CH, the mean value found was 138.2 l/
min, and for grade III CH, the mean value found was 116.4 
l/min. In this regression, the p value was 0.008.
The mean NIPF value for  rhinitis patients was 
114,0 l/min, and for those without it, the mean value found 
was 154.3 l/min, with a p value < 0.001.
As to the nasal obstruction complaint, the mean 
NIPF for those without rhinitis was 151.4 l/min and 123.6 
l/min for those with obstruction, with a p value of 0.002. 
DSN, race and gender were not statistically significant.
Table 4, shows a significant association (p=0,.02) 
between the values found in the visual analogue scale 
and NIPF. The same was not seen between age and NIPF.
In the Graph 1, we notice a strong association be-
tween NIPF and VAS values, with a p<0.001.
Table 5 shows that the age and rhinitis variables 
were significant for NIPF values in a multiple linear re-
gression model.
DISCUSSION
Statistics show rhinitis prevalence between 30% 
and 40% in the population11, similarly to what is found in 
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Table 2. Clinical characteristics, according to the presence of rhinitis.
Clinical characteristics
Rhinitis
p ValueYes No
n % n %
Smoking     0.099¢
No 32 91.4 33 76.7  
Yes 3 8.6 10 23.3  
Exposure to inhaling chemical products     0.049¢
No 26 74.3 38 88.4  
Yes 9 25.7 5 11.6  
Home exposure to mold     0.581¢
No 29 82.9 38 88.4  
Yes 6 17.1 5 11.6  
Pet     0.065¢
No 16 45.7 29 69.0  
Yes 19 54.3 14 31.0  
Moisture     0.988¢
No 29 82.9 35 81.4  
Yes 6 17.1 8 18.6  
Nasal obstruction     <0.001¢
No 5 14.3 31 72.1  
Yes 30 85.7 12 27.9  
Rhinorrhea     <0.001¢
No 20 57.1 42 97.7  
Yes 15 42.9 1 2.3  
Pruritus     <0.001¢
No 12 34.3 39 90.7  
Yes 23 65.7 4 9.3  
Sneezing     <0.001¢
No 11 31.4 40 93.0  
Yes 24 68.6 3 7.0  
Tearing     <0.001¢
No 23 65.7 42 97.7  
Yes 12 34.3 1 2.3  
Nasal septum deviation     0.561¢
No 25 71.4 33 76.7  
Yes 10 28.6 10 23.3  
Nasal secretion (rhinoscopy)     0.011£
No 27 77.1 42 97.7  
Yes 8 22.9 1 2.3  
Nasal secretion (nasal fibroscopy)     0.002¢
No 25 71.4 42 97.7  
Yes 10 28.6 1 2.3  
£ Fisher’s exact test. (n=78).
¢ Pearson’s chi-square test.
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Table 3. NIPF comparison according to sample demographic and clinical characteristics.
Characteristics n Mean
Standard 
deviation
Median 1st quartile 3rd quartile Minimum Maximum p-value
Gender         0,631¥
F 47 134.7 43.0 130 100 150 50 250  
M 31 139.0 31.8 140 120 155 50 200  
Ethnicity         0.999£
White 63 136.3 41.8 130 110 150 50 250  
Black 6 136.7 28.0 140 110 160 100 170  
Other 9 136.7 20.6 150 130 150 100 160  
Rhinitis         <0.001¥
No 43 154.3 37.7 150 125 170 90 250  
Yes 35 114.0 27.4 115 100 130 50 160  
Inferior nasal turbinate hypertrophye         0.008£
0 11 163.0a 42.3 150 150 200 100 250  
1 13 141.2 41.0 130 110 170 100 240  
2 33 138.2a.b 40.8 150 120 155 50 220  
3 21 116.4a.b 19.4 110 100 130 80 150  
Nasal obstruction         0.002¥
No 36 151.4 42.5 150 115 180 60 250  
Yes 42 123.6 30.3 127.5 100 150 50 200  
Nasal Septum deviation         0.878¥
No 58 136.8 39.0 130 110 150 50 250  
Yes 20 135.3 39.1 140 100 150 50 200  
¥ Student’s t-test (n=78).
£ Variance analysis test (ANOVA).
e Equal symbols have statistically significant differences (p<0.05), according to Bonferroni’s test.
Table 4. Spearman correlation coefficient (r) between NIPF 
with VAS and age.
 r Valor p
Age -0.15 0.2
VAS -0.41 <0.001
(n=78)
the present paper, which was of 44.9%. In the US alone, 
there are approximately 40 million people with allergic 
rhinitis12. As far as the nasal septum is concerned, 25% of 
the individuals had an obstructive deviation. In 2008, au-
thors published in the literature that 75% and 80% of the 
people have nasal anatomic changes, most of them with 
nasal septum deviation13. Later on, in 2009, other authors 
showed that statistics concerning nasal septum deviations 
are different, mostly because of the difficulty in classifying 
deviations in obstruction shape and intensity14.
Graph 1. Correlation between the NIPF and the Visual Analogue Scale 
(n=78).
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NIPF, as well as rhinometry, is an important comple-
mentary test to support diagnosis of nasal function and 
structural changes. In the present study, we found rhinitis 
patients with a mean NIPF value between 114 l/min and 
154.3 l/min in healthy individuals. This difference was sta-
tistically significant, which corroborates to the use of NIPF 
in the diagnosis of obstruction. In the literature, authors 
usually adopt a cutting point of 120 l/min for symptomatic 
individuals, and sensitivity and specificity higher than 75%7.
Mucha et al.12 have already used the NIPF as an 
instrument in the assessment and treatment of individu-
als with allergic rhinitis, thus showing its usefulness in 
patients with this disease. Bhatia et al.15 also utilized the 
NIPF as the only assessment method for nasal patency 
improvement in seasonal rhinitis, comparing the treatment 
between desloratadine and intranasal budesonide. In the 
present study, we noticed a significant increase in NIPF 
values comparing the values before the treatment in both 
groups (p<0.01)15.
Lund et al. 16 utilized the NIPF, together with the 
acoustic rhinometry to compare the response to intrana-
sal treatment with fluticasone and beclometasone in the 
severe nasal polyposis. They found a mean NIPF increase 
after treatment, from 76 l/min after the symptomatic use 
of fluticasone and 69 l/min with beclometasone in rela-
tion to the basal values, showing a statistically significant 
difference between the two groups16.
McWhorter et al.17, studied the role of the soft-palate 
tensor muscle in upper airway collapse, and observed that 
after its electrical stimulation, there was a 25% increase in 
the nasal inspiratory peak flow mean value. This shows 
that the NIPF is useful to help detect palate deformities.
As we could see, in the numerous papers men-
tioned, nasal patency checking with NIPF has been well 
established, in the presence of rhinitis, nasal polyps, in 
the assessment of treatment, comparing nasal anti-inflam-
matory treatment modalities and the presence of structural 
deformities. NIPF is sensitive to detect changes to the nasal 
conchae size, since these are directly associated with na-
sal flow resistance. According to some authors, the nasal 
obstruction pathogenesis is complex, and it depends on 
three main events: mucosa inflammatory edema, vascular 
congestion and mucosa hypersecretion18. Thus, the same 
rationale is applicable to the presence of rhinitis. Thus, 
NIPF can be used in the diagnosis of small changes to 
the nasal patency, such as, for example, in nasal mucosa 
provocation tests.
The first publications regarding its use started to 
appear in the mid 90’s3,9. Notwithstanding, most of the 
papers are recent and done abroad, which shows that 
such method is not widely used in Brazil.
In the present study, we noticed that the following 
variables: nasal obstruction, nasal conchae hypertrophy 
(CH) and rhinitis were predictive of the values found for 
by NIPF.
Some authors showed that acoustic rhinitis asso-
ciated with anterior rhinomanometry was more sensitive 
than the NIPF to detect changes to the nasal patency, for 
assessing each nasal cavity individually, which takes into 
account the nasal cycle and possible septum deviations. 
The NIPF detects the nasal inspiratory peak flow as the 
summation of the values obtained from both nasal cavities 
simultaneously, disregarding the fact that each nasal cavity, 
separately, with a good applicability to detect changes to 
the nasal patency as a whole19.
Considering Graph 1, there was a linear correlation 
between the NIPF value and the Visual Analogue Scale 
(p=0.002), in other words, the greater the nasal obstruction 
reported by the participant, the lower the expected NIPF 
value. Similar values were obtained in a study in which 
they reported a strong association  between the VAS and 
the acoustic rhinometry for nasal obstruction (p < 0.001), 
making it useful to predict nasal obstruction. Still, accord-
ing to the authors, the VAS can be used in clinical practice 
to quantify the nasal obstruction20. We did not find in the 
literature any correlation between the NIPF and VAS.
Lund and Scadding21 did a study analyzing the ob-
jective measures of nasal cavity endoscopic surgery, which 
showed that the NIPF or the rhinomanometry improved 
after surgery, despite important subjective improvements 
reported by the patients insofar as the nasal obstruction is 
concerned. Nonetheless, Marais et al.22 showed increases 
in NIPF after septoplasty, as did Cook et al.23 after laser 
treatment for rhinitis.
The NIPF has been utilized to assess the efficacy 
of nasal dilating agents, when used to manage nasal wing 
collapse during inspiratory maneauvers24 during intensive 
exercise25 or longstanding26,27. More recently, Bjornsdottir 
Table 5. Results from the peak-flow multiple linear regression.
 Coefficient (b)
Standard 
deviation
t p>t
Intercepto 135.6 15.4 8.82 <0.001
RHINITIS (N/S) 34.7 11.9 2.91 0.005
VAS -0.5 1.9 -0.27 0.788
Nasal obstruction 
(N/S)
4.4 9.8 0.45 0.652
Nasal conchae 
hypertrophy (ref=3)
    
0 20.3 13.4 1.51 0.135
1 6.1 12.9 0.48 0.635
2 11.8 9.5 1.24 0.220
Age -0.7 0.3 -2.32 0.023
Determination coefficient R2=36.7% (n=78).
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et al.28 examined the effect on individuals allergic to cat 
hair, and showed that after proper treatment, there was a 
significant improvement in NIPF values and better symp-
tom scores, when compared to a control group.
And finally, in the multiple regression model, rhinitis 
(p=0.005) and age (p=0.023) were significant. As rhinitis 
was added to the model, variables such as: obstruction, 
rhinorrhea, nasal conchae hypertrophy, pruritus and 
tearing, which are cardinal for the diagnosis of rhinitis, 
lost strength when analyzed alone. Now, as far as age is 
concerned, the higher it is, the lower the expected value 
for the NIPF. This is due to a probable anatomical change 
to the nasal tip and narrowing of the internal nasal valve, 
usually seen as age increases2,6.
Therefore, NIPF is one more tool in our existing 
arsenal, to aid in the diagnosis as well as to follow up on 
nasal clinical or surgical treatments. It is simple and easy 
to handle device; not expensive and reproducible.
CONCLUSION
Nasal Inspiratory Peak Flow (NIPF) proved to be a 
reliable method to detect changes to nasal patency due to 
obstructive or inflammatory causes. It indicated a pattern 
of definitive values, with one acceptable statistical signifi-
cance, for individuals with and without rhinitis. 
Nonetheless, further studies are needed in order to 
totally understand and standardize the use of NIPF.
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